Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.39), $0.11 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $477 thousand versus the consensus estimate of $470 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.